Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia V Gelsi‐Boyer, V Trouplin, J Adélaïde, J Bonansea, N Cervera, ... British journal of haematology 145 (6), 788-800, 2009 | 733 | 2009 |
Gene expression profiling of breast cell lines identifies potential new basal markers E Charafe-Jauffret, C Ginestier, F Monville, P Finetti, J Adelaïde, ... Oncogene 25 (15), 2273-2284, 2006 | 691 | 2006 |
Prognostic and predictive value of PDL1 expression in breast cancer R Sabatier, P Finetti, E Mamessier, J Adelaide, M Chaffanet, HR Ali, ... Oncotarget 6 (7), 5449, 2015 | 549 | 2015 |
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER) F André, T Bachelot, F Commo, M Campone, M Arnedos, V Dieras, ... The lancet oncology 15 (3), 267-274, 2014 | 445 | 2014 |
Integrated profiling of basal and luminal breast cancers J Adélaïde, P Finetti, I Bekhouche, L Repellini, J Geneix, F Sircoulomb, ... Cancer research 67 (24), 11565-11575, 2007 | 432 | 2007 |
Mutations of ASXL1 gene in myeloproliferative neoplasms N Carbuccia, A Murati, V Trouplin, M Brecqueville, J Adelaide, J Rey, ... Leukemia 23 (11), 2183-2186, 2009 | 431 | 2009 |
Characterization of the HST-related FGF. 6 gene, a new member of the fibroblast growth factor gene family. I Marics, J Adelaide, F Raybaud, MG Mattei, F Coulier, J Planche, ... Oncogene 4 (3), 335-340, 1989 | 381 | 1989 |
ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor JP Borg, S Marchetto, A Le Bivic, V Ollendorff, F Jaulin-Bastard, H Saito, ... Nature cell biology 2 (7), 407-414, 2000 | 371 | 2000 |
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers F Bertucci, P Finetti, N Cervera, E Charafe-Jauffret, E Mamessier, ... Cancer research 66 (9), 4636-4644, 2006 | 355 | 2006 |
Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction N Reymond, S Fabre, E Lecocq, J Adelaıde, P Dubreuil, M Lopez Journal of Biological Chemistry 276 (46), 43205-43215, 2001 | 349 | 2001 |
Gene expression profiling of primary breast carcinomas using arrays of candidate genes F Bertucci, R Houlgatte, A Benziane, S Granjeaud, J Adélaïde, R Tagett, ... Human Molecular Genetics 9 (20), 2981-2991, 2000 | 304 | 2000 |
Protein expression profiling identifies subclasses of breast cancer and predicts prognosis J Jacquemier, C Ginestier, J Rougemont, VJ Bardou, E Charafe-Jauffret, ... Cancer Research 65 (3), 767-779, 2005 | 298 | 2005 |
Expression of FGF and FGF receptor genes in human breast cancer F Penault‐Llorca, F Bertucci, J Adélaïde, P Parc, F Coulier, J Jacquemier, ... International journal of cancer 61 (2), 170-176, 1995 | 298 | 1995 |
Comprehensive profiling of 8p11-12 amplification in breast cancer V Gelsi-Boyer, B Orsetti, N Cervera, P Finetti, F Sircoulomb, C Rougé, ... Molecular Cancer Research 3 (12), 655-667, 2005 | 270 | 2005 |
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia V Gelsi‐Boyer, V Trouplin, J Roquain, J Adélaïde, N Carbuccia, B Esterni, ... British journal of haematology 151 (4), 365-375, 2010 | 248 | 2010 |
WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type F Ugolini, E Charafe-Jauffret, VJ Bardou, J Geneix, J Adélaïde, ... Oncogene 20 (41), 5810-5817, 2001 | 221 | 2001 |
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers C Ginestier, E Charafe-Jauffret, F Bertucci, F Eisinger, J Geneix, ... The American journal of pathology 161 (4), 1223-1233, 2002 | 201 | 2002 |
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization R Sabatier, P Finetti, A Guille, J Adelaide, M Chaffanet, P Viens, ... Molecular cancer 13, 1-14, 2014 | 197 | 2014 |
Detailed map of a region commonly amplified at 11q13→ q14 in human breast carcinoma S Bekri, J Adelaide, S Merscher, J Grosgeorge, F Caroli-Bosc, ... Cytogenetic and Genome Research 79 (1-2), 125-131, 1997 | 195 | 1997 |
Nectin-4 is a new histological and serological tumor associated marker for breast cancer S Fabre-Lafay, F Monville, S Garrido-Urbani, C Berruyer-Pouyet, ... BMC cancer 7, 1-16, 2007 | 191 | 2007 |